hu14

· Renaissance Pharma Ltd.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for hu14, covering 2026-04-24 to 2026-04-24. Get the full timeline:

Most recent: Clinical Trial Update: A Safety and Efficacy Study of hu14 in High-Risk Neuroblastoma Patients [Phase 2, Phase 3]